COVID-19 and Oncology: Service transformation during pandemic
- PMID: 32810386
- PMCID: PMC7461476
- DOI: 10.1002/cam4.3384
COVID-19 and Oncology: Service transformation during pandemic
Abstract
Background: The COVID-19 pandemic has challenged healthcare systems around the world, where resources have refocused on increasing critical bed capacity to prepare for the peak in incidence of COVID-19. Oncology faces an unprecedented challenge as patients require multidisciplinary care and are more likely to be immunosuppressed. Services in oncology have been transformed using minimal resources over a short period of time. This transformation continues and telemedicine is playing a key role.
Aims: We explore how services in oncology have transformed to deliver services including consultations, systemic anticancer therapy, and surgery for patients, while shielding them from contracting COVID-19. We assess the risks and benefits of the service transformation in the immediate, interim, and long term, and how telemedicine supports the process.
Methods: We performed a comprehensive review of the literature using suitable keywords on the search engines of PubMed, SCOPUS, Google Scholar, and latest official data from May to June 2020.
Results: Through the published literature on this topic, we discuss the transformations in oncology and the impact on patients and healthcare workers due to the COVID-19 pandemic. We reflect on the lessions from COVID-19 and assess the role of telemedicine in the future of oncology services.
Conclusion: Transformation of services in oncology effectively shields patients from COVID-19 infections, and telemedicine plays a role in virtual consultations. The long-term effects are yet to be seen, such as safety of home-based treatment, and effectiveness of virtual communication on patient care. As oncology requires a multidisciplinary approach, telemedicine will play a key role to improve patient-centered cancer care in the future.
Keywords: COVID-19; SARS-CoV-2; chemotherapy; oncology service; systemic anticancer therapy; telemedicine.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures



References
-
- WHO . Coronavirus disease: (COVID‐19) Situation Report – 136. 4 June 2020.
-
- Coronavirus (COVID‐19) in the UK . UK Government: Public Health England (PHE), 5 Jun 2020.
-
- Speech: PM address to the nation on coronavirus: 23 March 2020 . The Rt Hon Boris Johnson MP, Prime Minister's Office, 10 Downing Street 23 Mar 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous